Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Double blind placebo controlled trial of steroids in Bacterial Meningitis
ISRCTN ISRCTN42986828
ClinicalTrials.gov identifier
Public title Double blind placebo controlled trial of steroids in Bacterial Meningitis
Scientific title
Acronym BM Study
Serial number at source 061330
Study hypothesis To investigate the effects of dexamethazone on the course and outcome of Bacterial Meningitis (BM) in adults in Viet Nam.
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Viet Nam
Disease/condition/study domain Bacterial meningitis
Participants - inclusion criteria 1. The treating physician believes the diagnosis to be BM
2. History less than ten days (unless still Serebrospinal Fluid [CSF] evidence of bacteria)
3. CSF white cell count more than 50 with more than 50% neutrophils
4. CSF glucose less than 50% of blood glucose
Participants - exclusion criteria 1. Chest X-Ray (CXR) shows evidence of possible Tuberculosis (TB)
2. History is longer than ten days
3. History of hypersensitivity to beta-lactam antibiotics
4. Known severe liver or renal impairment
5. Patients in whom the physician believes corticosteroids are contraindicated e.g. uncontrolled diabetes, gastro-intestinal bleeding etc.
6. Pre-existing severe neurological disability
7. Pregnancy within the first trimester
Anticipated start date 01/11/1996
Anticipated end date 01/01/2000
Status of trial Completed
Patient information material
Target number of participants To be added
Interventions Double blind randomised controlled trial. The intervention will be dexamethasone.
Primary outcome measure(s) Mortality
Secondary outcome measure(s) No secondary outcome measures
Sources of funding The Wellcome Trust (UK) (grant ref: 061330)
Trial website
Publications Results in:
1. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&list_uids=15496623
2. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&list_uids=18077808
Contact name Dr  Jeremy  Farrar
  Address Hospital for Tropical Diseases
The Hospital for Tropical Diseases
Oxford University Clinical Research
190 Ben Ham Tu
  City/town Ho Chi Minh City
  Zip/Postcode 5
  Country Viet Nam
  Tel +84 8 8362225
  Fax +84 8 9238904
  Email jeremyjf@hcm.vnn.vn
Sponsor University of Oxford (UK)
  Address University Offices
Wellington Square
  City/town Oxford
  Zip/Postcode OX1 2JD
  Country United Kingdom
  Tel +44 (0)1865 270143
  Fax +44 (0)1865 280467
  Email research.services@admin.ox.ac.uk
  Sponsor website: http://www.ox.ac.uk
Date applied 22/07/2005
Last edited 18/12/2007
Date ISRCTN assigned 22/07/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central